fbpx

Weight Loss Program With Saxenda & Ozempic In Malaysia

Cliniccleo®

WHEN IT COMES TO LOSING WEIGHT AND KEEPING IT OFF

Managing a long-term disease like obesity requires more than willpower alone. Adding Saxenda® to a reduced-calorie meal plan and increased physical activity may help you lose weight and keep it off.

Ozempic & Saxenda Treatment Overview

We are proud to offer expert weight management with the revolutionary first line drug Saxenda® or use of Ozempic for diabetes patients. Our physicians can prescribe Saxenda or Ozempic as part of your holistic weight loss programme. 

Saxenda can help you lose weight to improve your health and boost your wellbeing. 

Weight loss involves managing your portion sizes, improving your daily eating habits, and daily exercise, but it’s not always that easy. 

We understand just how challenging it can be to maintain weight loss results on your own. 

Here at CLEO Clinic, we are here to provide a helping hand. We offer first-class weight loss treatment and guidance in a calm and supportive environment. 

Achieving a healthy weight can also reduce your risk of developing long term conditions. These include type 2 diabetes, heart disease and certain types of cancers. 

In year-long clinical trials, most patients taking Saxenda or Ozempic lost weight and, most importantly, kept it off. 

Weight loss medication is a treatment option we offer for obese patients to help you manage your weight.

The aim after using weight loss medication is to maintain a healthy BMI on a long-term basis. 

Cliniccleo®

What other options TO LOSE WEIGHT?

At CLEO clinic our weight loss program approach each individual holistically with a multimodality approach to achieve the most sustainable and heathy weight loss. We believe in combination of treatments that is customize to its needs . It is important to understand the timeline of these combination therapies as the timing of combination treatments depends on the modalities and mechanisms of action. Each patient is unique, and clinical improvement may vary significantly among patients. For a more accurate diagnosis and treatment regime , we would advise patients to come for a free consultation with our lovely doctors.

Cliniccleo®

HOW SHOULD I USE SAXENDA®?

  • Read the Instructions for Use that comes with Saxenda®
  • Inject your dose of Saxenda® under the skin (subcutaneously) in your stomach area (abdomen), upper leg (thigh), or upper arm, as instructed by your health care provider. Do not inject into a vein or muscle
  • Change (rotate) your injection site within the area you choose with each injection to reduce your risk of getting lumps under the skin (cutaneous amyloidosis). Do not use the same site for each injection

WHAT ARE THE POSSIBLE SIDE EFFECTS OF SAXENDA®?

Saxenda® may cause serious side effects, including:

  • inflammation of the pancreas (pancreatitis)
  • gallbladder problems
  • increased heart rate
  • kidney problems 
  • Allergic reactions
  • depression or thoughts of suicide

The most common side effects of Saxenda® in adults include nausea, diarrhea, constipation, vomiting, injection site reaction, low blood sugar (hypoglycemia), headache, tiredness (fatigue), dizziness, stomach pain, and change in enzyme (lipase) levels in your blood. Additional common side effects in children are fever and gastroenteritis.

Cliniccleo®

WHO SHOULD NOT USE SAXENDA?

Do not use Saxenda® if:

  • you or any of your family have ever had MTC or if you have MEN 2
  • you have had a serious allergic reaction to liraglutide or any of the ingredients in Saxenda®. See symptoms of serious allergic reactions in “What are the possible side effects of Saxenda®?”
  • you are pregnant or plan to become pregnant. Saxenda® may harm your unborn baby

Before taking Saxenda®, tell your health care provider about all of your medical conditions, including if you:

  • are taking certain medicines called GLP-1 receptor agonists
  • have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food provider should decide if you will use Saxenda® or breastfeed

Tell your health care provider about all the medicines you take, including prescription, over-the-counter medicines, vitamins, and herbal supplements. 

Cliniccleo®

INDICATION AND IMPORTANT SAFETY INFORMATION

Do not share your Saxenda® pen with others even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT SAXENDA®?

Serious side effects may happen in people who take Saxenda®, including: Possible thyroid tumors, including cancer. Tell your health care professional if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Saxenda® and medicines that work like Saxenda® caused thyroid tumors, including thyroid cancer. It is not known if Saxenda® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not use Saxenda® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Weight Loss Treatments With Ozempic Kuala Lumpur

We offer the following treatments to help you in your weight loss and diabetes journey. All treatment options are subject 
to approval by our prescriber following the completion and assessment the medical consultation by our qualified physicians

Ozempic

(Semaglutide Injections)

RYBELSUS

(Semaglutide PILLS)

SAXENDA

(Liraglutide Injections)

What is the difference between Saxenda (Liraglutide) and Ozempic (Semaglutide)?

Saxenda (Liraglutide 3.0mg) and Ozempic (semaglutide) are both GLP-1 analogues, which means they behave like the naturally produced hormone called Glucagon Like Peptide (GLP-1). Semaglutide has a longer duration of action than Liraglutide, hence it is a once-weekly injection.

Saxenda has a license to specifically treat weight-loss, whereas Semaglutide, although a licensed medication for diabetes and very effective in treating weight loss, is awaiting full approval to do so.

Semaglutide is a once weekly injection whereas Liraglutide 3mg (Saxenda) injection has to be given every day. This because Semaglutide has a longer duration of action in the body. 

The current available maximum dose of semaglutide (Ozempic) is 1mg, which is licensed to treat diabetes. The anticipated dose to treat weight loss weight loss will be 2.4mg, where another drug (Wegovy) is in the process of approval. 

Off label prescription OF OZEMPIC?

When a physician gives you a drug that the Food and Drug Administration (FDA) has approved to treat a condition different than your condition.

What is off-label prescribing?

Off-label prescribing is when you are prescribed a licensed medication to treat a condition not specifically stated or listed on its product license.

Prescribing outside of these guidelines included with the license of any medicine means that it is being used “off-label”. Our physicians at the CLEO Clinic will only prescribe off-label if they believe that the medication will be effective at treating the condition in question, and that the advantages outweigh any potential risks.

Off-label prescribing is fairly common and is a safe practice as long as the patient’s condition, medical history, allergies and current medicines are taken into consideration. Being prescribed a medicine off-label doesn’t mean that the drug is unlicensed – these two terms mean very different things and shouldn’t be confused with each other. 

WHAT IS WEGOVY ?

Semaglutide (Wegovy) launched in the UK on 4 September and is available only in europe as an option for weight management , alongside a reduced-calorie diet and increased physical activity.

  •  Wegovy is the brand name for semaglutide, which is licensed and approved for managing overweight and obesity. It is manufactured by Novo Nordisk and is recommended by the National Institute for Health and Care Excellence (NICE) for managing overweight and obesity in some patients in the UK.
  • Clinical trials indicate that when used alongside diet, physical activity, and behavioural support, Wegovy users can achieve up to a 15% reduction in body weight after one year.
  • Ozempic is another brand name for semaglutide, which is identical to Wegovy but being used to treat type 2 diabetes. 
  • In the region WeGovy has received approval from the Health Sciences Authority of Singapore as a weight loss medicine. However, in malaysia it has yet to be approved by the misnitry of health. 

Trusted by hundreds of satisfied clients 5⭐️ reviews on google